403 related articles for article (PubMed ID: 16417600)
1. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations.
Tan EK
Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600
[TBL] [Abstract][Full Text] [Related]
2. [Treatment with botulinum toxin in neurologic pediatrics].
Justus N; Lee SH; Berweck S; Heinen F
Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
[No Abstract] [Full Text] [Related]
3. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
Wilken B; Aslami B; Backes H
Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
[TBL] [Abstract][Full Text] [Related]
4. Drooling: are botulinum toxin injections into the major salivary glands a good treatment option?
Nordgarden H; Østerhus I; Møystad A; Asten P; Johnsen UL; Storhaug K; Loven JØ
J Child Neurol; 2012 Apr; 27(4):458-64. PubMed ID: 21940695
[TBL] [Abstract][Full Text] [Related]
5. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.
Petracca M; Guidubaldi A; Ricciardi L; Ialongo T; Del Grande A; Mulas D; Di Stasio E; Bentivoglio AR
Toxicon; 2015 Dec; 107(Pt A):129-40. PubMed ID: 26327120
[TBL] [Abstract][Full Text] [Related]
6. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.
Chinnapongse R; Gullo K; Nemeth P; Zhang Y; Griggs L
Mov Disord; 2012 Feb; 27(2):219-26. PubMed ID: 21887710
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
[No Abstract] [Full Text] [Related]
9. Botulinum toxin type B for sialorrhea in children with cerebral palsy.
Reddihough D; Graham HK
Dev Med Child Neurol; 2011 Jun; 53(6):488-9. PubMed ID: 21501158
[No Abstract] [Full Text] [Related]
10. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?
Vaile L; Finlay F
Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361
[No Abstract] [Full Text] [Related]
11. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
Verma A; Steele J
Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease.
Contarino MF; Pompili M; Tittoto P; Vanacore N; Sabatelli M; Cedrone A; Rapaccini GL; Gasbarrini G; Tonali PA; Bentivoglio AR
Parkinsonism Relat Disord; 2007 Jul; 13(5):299-303. PubMed ID: 16807056
[TBL] [Abstract][Full Text] [Related]
14. Safety of Ultrasound-Guided Botulinum Toxin Injections for Sialorrhea as Performed by Pediatric Otolaryngologists.
Shariat-Madar B; Chun RH; Sulman CG; Conley SF
Otolaryngol Head Neck Surg; 2016 May; 154(5):924-7. PubMed ID: 26908558
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.
Basciani M; Di Rienzo F; Fontana A; Copetti M; Pellegrini F; Intiso D
Dev Med Child Neurol; 2011 Jun; 53(6):559-64. PubMed ID: 21413974
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin as an effective treatment of clozapine-induced hypersalivation.
Kahl KG; Hagenah J; Zapf S; Trillenberg P; Klein C; Lencer R
Psychopharmacology (Berl); 2004 Apr; 173(1-2):229-30. PubMed ID: 14747903
[TBL] [Abstract][Full Text] [Related]
17. Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin.
Egevad G; Petkova VY; Vilholm OJ
J Parkinsons Dis; 2014; 4(3):321-6. PubMed ID: 24919823
[TBL] [Abstract][Full Text] [Related]
18. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
Ondo WG; Hunter C; Moore W
Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin for the treatment of sialorrhea: a meta-analysis.
Vashishta R; Nguyen SA; White DR; Gillespie MB
Otolaryngol Head Neck Surg; 2013 Feb; 148(2):191-6. PubMed ID: 23112272
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin therapy of migraine and tension-type headache: comparing different botulinum toxin preparations.
Schulte-Mattler WJ; Martinez-Castrillo JC
Eur J Neurol; 2006 Feb; 13 Suppl 1():51-4. PubMed ID: 16417598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
